DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Dasatinib, Atc L01ea02 for the Period 04/01/2023 - 03/31/2025. The project location is Germany and the tender is closing on 05 Feb 2025. The tender notice number is -, while the TOT Ref Number is 79128532.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Dasatinib, Atc L01ea02 for the Period 04/01/2023 - 03/31/2025
Sign in with Google